Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 1
2013 1
2014 1
2015 1
2019 1
2020 2
2021 1
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Promising effect of intravenous immunoglobulin therapy for epidermolysis bullosa pruriginosa.
Ertop P, Vural S, Gökpınar Ili E, Durmaz CD, Heper AO, McGrath JA, Ilgın RH, Boyvat A. Ertop P, et al. Int J Dermatol. 2020 Jul;59(7):851-855. doi: 10.1111/ijd.14951. Epub 2020 Jun 7. Int J Dermatol. 2020. PMID: 32506551
BACKGROUND: Epidermolysis bullosa pruriginosa (EBP) is rare a clinical variant of dystrophic epidermolysis bullosa characterized by trauma-induced bullae formation, milia and nail dystrophy accompanied by severe pruritus. ...AIM: To provide the genetic …
BACKGROUND: Epidermolysis bullosa pruriginosa (EBP) is rare a clinical variant of dystrophic epidermolysis bullo …
Review of thalidomide use in the pediatric population.
Yang CS, Kim C, Antaya RJ. Yang CS, et al. J Am Acad Dermatol. 2015 Apr;72(4):703-11. doi: 10.1016/j.jaad.2015.01.002. Epub 2015 Jan 21. J Am Acad Dermatol. 2015. PMID: 25617013 Review.
Thalidomide is second-line treatment for aphthous stomatitis and chronic graft-versus-host disease in children and has been prescribed for many other conditions including actinic prurigo and epidermolysis bullosa pruriginosa. Systemic lupus erythematosus may …
Thalidomide is second-line treatment for aphthous stomatitis and chronic graft-versus-host disease in children and has been prescribed for m …
Epidermolysis Bullosa Pruriginosa successfully treated with concomitant topical and systemic agents.
Ferreira S, Azevedo A, Velho GC, Sanches M, Selores M. Ferreira S, et al. Australas J Dermatol. 2020 Nov;61(4):355-357. doi: 10.1111/ajd.13342. Epub 2020 Jun 10. Australas J Dermatol. 2020. PMID: 32524588
Epidermolysis bullosa pruriginosa, a genetic mechanobullous disease, manifests at birth or late in life and is characterised by intense pruritus, resulting in lichenified or nodular prurigo-like lesions and scarring most prominent on the shins. ...
Epidermolysis bullosa pruriginosa, a genetic mechanobullous disease, manifests at birth or late in life and is characte …
Pruritus Anesis in Dystrophic Epidermolysis Bullosa Pruriginosa with Dupilumab.
Yang DY, Jing WW, Liu X, Li L, Lu T, Li XL. Yang DY, et al. Adv Skin Wound Care. 2024 Feb 1;37(2):1-4. doi: 10.1097/ASW.0000000000000096. Adv Skin Wound Care. 2024. PMID: 38241457
Dystrophic epidermolysis bullosa pruriginosa (DEB-Pr) is a rare subtype of dystrophic epidermolysis bullosa, and traditional treatments have limited efficacy. ...
Dystrophic epidermolysis bullosa pruriginosa (DEB-Pr) is a rare subtype of dystrophic epidermolysis bullosa, and tradit …
Epidermolysis bullosa pruriginosa showing good response to low-dose thalidomide - a report of two cases.
Ranugha PS, Mohanan S, Chandrashekar L, Basu D, Thappa DM, Rajesh NG. Ranugha PS, et al. Dermatol Ther. 2014 Jan-Feb;27(1):60-3. doi: 10.1111/dth.12047. Epub 2013 Apr 2. Dermatol Ther. 2014. PMID: 24502315
Epidermolysis bullosa pruriginosa is a rare distinctive variant of dystrophic epidermolysis bullosa characterized by intense pruritus, lichenified plaques in linear distribution, and anonychia. ...The present authors report two cases showing good response to …
Epidermolysis bullosa pruriginosa is a rare distinctive variant of dystrophic epidermolysis bullosa characterized by in …
Thalidomide in the management of epidermolysis bullosa pruriginosa.
Ozanic Bulic S, Fassihi H, Mellerio JE, McGrath JA, Atherton DJ. Ozanic Bulic S, et al. Br J Dermatol. 2005 Jun;152(6):1332-4. doi: 10.1111/j.1365-2133.2005.06492.x. Br J Dermatol. 2005. PMID: 15949003
Epidermolysis bullosa (EB) pruriginosa is a distinctive clinical subtype of dystrophic EB. We report a patient with dominant dystrophic EB pruriginosa, who had an excellent response to systemic thalidomide treatment. ...
Epidermolysis bullosa (EB) pruriginosa is a distinctive clinical subtype of dystrophic EB. We report a patient with dominant dystroph …
13 results